Equillium to Participate in Upcoming Investor Conferences

LA JOLLA, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that management will participate in the following upcoming investor conferences: Cantor Global Healthcare Conference 2026 Format: Fireside Chat & 1x1 Meetings Date: Wednesday, September 9, 2026 Time: 9:45 AM EDT Webcast Link: Here H.C. Wainwright 28th Annual Global Investment Conference Format: Company Presentation & 1x1 Meetings Date: Monday, September 14, 2026 Time: 11:00 AM EDT Members of the Equillium management team will be available to meet with investors who are registered to attend the conference. A live webcast of the Cantor fireside chat may also be accessed on the Events & Presentations page, located under the Investor Relations section on equilliumbio.com. A replay of the webcast will be available for approximately 45 days following the conference. About Equillium Equillium is a biotechnology innovator with a mission to develop highly impactful therapies to treat severe autoimmune and inflammatory disorders. For more information, visit www.equilliumbio.com. Investor Contact PJ Kelleher LifeSci Advisors, LLC +1-617-430-7579 [email protected] Source: Equillium, Inc.